189 related articles for article (PubMed ID: 19640014)
1. How to deal with cost differences at baseline.
van Asselt AD; van Mastrigt GA; Dirksen CD; Arntz A; Severens JL; Kessels AG
Pharmacoeconomics; 2009; 27(6):519-28. PubMed ID: 19640014
[TBL] [Abstract][Full Text] [Related]
2. Out-patient psychotherapy for borderline personality disorder: cost-effectiveness of schema-focused therapy v. transference-focused psychotherapy.
van Asselt AD; Dirksen CD; Arntz A; Giesen-Bloo JH; van Dyck R; Spinhoven P; van Tilburg W; Kremers IP; Nadort M; Severens JL
Br J Psychiatry; 2008 Jun; 192(6):450-7. PubMed ID: 18515897
[TBL] [Abstract][Full Text] [Related]
3. Outpatient psychotherapy for borderline personality disorder: randomized trial of schema-focused therapy vs transference-focused psychotherapy.
Giesen-Bloo J; van Dyck R; Spinhoven P; van Tilburg W; Dirksen C; van Asselt T; Kremers I; Nadort M; Arntz A
Arch Gen Psychiatry; 2006 Jun; 63(6):649-58. PubMed ID: 16754838
[TBL] [Abstract][Full Text] [Related]
4. Difficulties in calculating productivity costs: work disability associated with borderline personality disorder.
van Asselt AD; Dirksen CD; Arntz A; Severens JL
Value Health; 2008; 11(4):637-44. PubMed ID: 18179672
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness and Budget Impact of Specialized Psychotherapy for Borderline Personality Disorder: A Synthesis of the Evidence.
Wetzelaer P; Lokkerbo J; Arntz A; van Aselt T; Smit F; Evers S
J Ment Health Policy Econ; 2017 Dec; 20(4):177-190. PubMed ID: 29300704
[TBL] [Abstract][Full Text] [Related]
6. The cost-effectiveness of short-term psychodynamic psychotherapy and solution-focused therapy in the treatment of depressive and anxiety disorders during a one-year follow-up.
Maljanen T; Paltta P; Harkanen T; Virtala E; Lindfors O; Laaksonen MA; Knekt P;
J Ment Health Policy Econ; 2012 Mar; 15(1):13-23. PubMed ID: 22611089
[TBL] [Abstract][Full Text] [Related]
7. The cost of borderline personality disorder: societal cost of illness in BPD-patients.
van Asselt AD; Dirksen CD; Arntz A; Severens JL
Eur Psychiatry; 2007 Sep; 22(6):354-61. PubMed ID: 17544636
[TBL] [Abstract][Full Text] [Related]
8. PRO*BPD: effectiveness of outpatient treatment programs for borderline personality disorder: a comparison of Schema therapy and dialectical behavior therapy: study protocol for a randomized trial.
Fassbinder E; Assmann N; Schaich A; Heinecke K; Wagner T; Sipos V; Jauch-Chara K; Hüppe M; Arntz A; Schweiger U
BMC Psychiatry; 2018 Oct; 18(1):341. PubMed ID: 30340474
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of psychotherapy for cluster B personality disorders.
Soeteman DI; Verheul R; Delimon J; Meerman AM; van den Eijnden E; Rossum BV; Ziegler U; Thunnissen M; Busschbach JJ; Kim JJ
Br J Psychiatry; 2010 May; 196(5):396-403. PubMed ID: 20435967
[TBL] [Abstract][Full Text] [Related]
10. Societal cost-of-illness in patients with borderline personality disorder one year before, during and after dialectical behavior therapy in routine outpatient care.
Wagner T; Fydrich T; Stiglmayr C; Marschall P; Salize HJ; Renneberg B; Fleßa S; Roepke S
Behav Res Ther; 2014 Oct; 61():12-22. PubMed ID: 25113523
[TBL] [Abstract][Full Text] [Related]
11. Probabilistic Markov model to assess the cost-effectiveness of bronchodilator therapy in COPD patients in different countries.
Oostenbrink JB; Rutten-van Mölken MP; Monz BU; FitzGerald JM
Value Health; 2005; 8(1):32-46. PubMed ID: 15841892
[TBL] [Abstract][Full Text] [Related]
12. Adjusting for Baseline Covariates in Net Benefit Regression: How You Adjust Matters.
Isaranuwatchai W; Markle-Reid M; Hoch JS
Pharmacoeconomics; 2015 Oct; 33(10):1083-90. PubMed ID: 25957531
[TBL] [Abstract][Full Text] [Related]
13. The therapeutic alliance in schema-focused therapy and transference-focused psychotherapy for borderline personality disorder.
Spinhoven P; Giesen-Bloo J; van Dyck R; Kooiman K; Arntz A
J Consult Clin Psychol; 2007 Feb; 75(1):104-15. PubMed ID: 17295569
[TBL] [Abstract][Full Text] [Related]
14. Economic evaluation of schema therapy and clarification-oriented psychotherapy for personality disorders: a multicenter, randomized controlled trial.
Bamelis LL; Arntz A; Wetzelaer P; Verdoorn R; Evers SM
J Clin Psychiatry; 2015 Nov; 76(11):e1432-40. PubMed ID: 26579561
[TBL] [Abstract][Full Text] [Related]
15. Psychotherapy with borderline patients: II. A preliminary cost benefit study.
Stevenson J; Meares R
Aust N Z J Psychiatry; 1999 Aug; 33(4):473-7; discussion 478-81. PubMed ID: 10483841
[TBL] [Abstract][Full Text] [Related]
16. Cost effectiveness of a pharmacy-based coaching programme to improve adherence to antidepressants.
Bosmans JE; Brook OH; van Hout HP; de Bruijne MC; Nieuwenhuyse H; Bouter LM; Stalman WA; van Tulder MW
Pharmacoeconomics; 2007; 25(1):25-37. PubMed ID: 17192116
[TBL] [Abstract][Full Text] [Related]
17. Lamotrigine versus inert placebo in the treatment of borderline personality disorder: study protocol for a randomized controlled trial and economic evaluation.
Crawford MJ; Sanatinia R; Barrett B; Byford S; Cunningham G; Gakhal K; Lawrence-Smith G; Leeson V; Lemonsky F; Lykomitrou G; Montgomery A; Morriss R; Paton C; Tan W; Tyrer P; Reilly JG
Trials; 2015 Jul; 16():308. PubMed ID: 26187496
[TBL] [Abstract][Full Text] [Related]
18. Population-based cost-offset estimation for the treatment of borderline personality disorder: projected costs in a currently running, ideal health system.
Wunsch EM; Kliem S; Kröger C
Behav Res Ther; 2014 Sep; 60():1-7. PubMed ID: 25014129
[TBL] [Abstract][Full Text] [Related]
19. A cost-effectiveness analysis of dialectical behaviour therapy for treating individuals with borderline personality disorder in the community.
Murphy A; Bourke J; Flynn D; Kells M; Joyce M
Ir J Med Sci; 2020 May; 189(2):415-423. PubMed ID: 31482522
[TBL] [Abstract][Full Text] [Related]
20. Complaint-Directed Mini-Interventions for Depressive Symptoms: A Health Economic Evaluation of Unguided Web-Based Self-Help Interventions Based on a Randomized Controlled Trial.
Wijnen BF; Lokman S; Leone S; Evers SM; Smit F
J Med Internet Res; 2018 Oct; 20(10):e10455. PubMed ID: 30274958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
